loadpatents
Patent applications and USPTO patent grants for TASUKU HONJO.The latest application filed is for "immunopotentiative composition".
Patent | Date |
---|---|
Immunopotentiative composition Grant 9,393,301 - Honjo , et al. July 19, 2 | 2016-07-19 |
Immunopotentiative Composition App 20150197572 - HONJO; Tasuku ;   et al. | 2015-07-16 |
Substance Specific To Human Pd-1 App 20150118234 - HONJO; Tasuku ;   et al. | 2015-04-30 |
Immunopotentiative Composition App 20150093380 - HONJO; Tasuku ;   et al. | 2015-04-02 |
Substance specific to human PD-1 Grant 8,246,955 - Honjo , et al. August 21, 2 | 2012-08-21 |
Substance Specific to Human PD-1 App 20090263865 - HONJO; Tasuku ;   et al. | 2009-10-22 |
Substance Specific to Human Pd-1 App 20080025979 - Honjo; Tasuku ;   et al. | 2008-01-31 |
Peptide related to human programmed cell death and DNA encoding it Grant 5,629,204 - Honjo , et al. May 13, 1 | 1997-05-13 |
Process for constructing cDNA library, and novel polypeptide and DNA coding for the same Grant 5,525,486 - Honjo , et al. June 11, 1 | 1996-06-11 |
Interleukin 2 receptor and a method for production thereof Grant 4,816,565 - Honjo , et al. March 28, 1 | 1989-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.